Study finds how new imaging method accurately detects kidney cancer
A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging ...
New imaging technique accurately detects aggressive kidney cancer
A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, ...
GlobalData on MSN1d
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...
Oncology Nurse Advisor1d
Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy
No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting.
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...
The Insighters Seeks Kidney Cancer Patients to Share Their Opinions in Research
The healthcare brand offers paid research opportunities for patients and family caregivers in the US New Hope, Pennsylvania-- ...
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that the Agenzia Italiana del Farmaco (AIFA) has approved a new Phase 1 ...
Too Old to Operate4d
Implications of Frailty Assessment in the Management of RCC in Older Adults
The following is a summary of “Frailty and Renal Cell Carcinoma: Integration of Comprehensive Geriatric Assessment into ...